T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma
- PMID: 28595519
- DOI: 10.2217/imt-2017-0053
T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma
Keywords: T cellular immunotherapies; hepatocellular carcinoma; tumor-associated antigen.
Similar articles
-
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.J Immunol Res. 2018 Mar 26;2018:8740976. doi: 10.1155/2018/8740976. eCollection 2018. J Immunol Res. 2018. PMID: 29785403 Free PMC article. Review.
-
Immunology of hepatocellular carcinoma.Ital J Gastroenterol. 1991 Nov;23(8):494-7. Ital J Gastroenterol. 1991. PMID: 1661196 Review.
-
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy.Dig Dis. 2012;30(5):483-91. doi: 10.1159/000341697. Epub 2012 Oct 24. Dig Dis. 2012. PMID: 23108304 Review.
-
Cancer vaccines for hepatocellular carcinoma: future directions.Immunotherapy. 2016;8(4):391-3. doi: 10.2217/imt-2015-0018. Immunotherapy. 2016. PMID: 26973120 No abstract available.
-
Chimeric antigen receptor-engineered T-cell therapy for liver cancer.Hepatobiliary Pancreat Dis Int. 2018 Aug;17(4):301-309. doi: 10.1016/j.hbpd.2018.05.005. Epub 2018 May 24. Hepatobiliary Pancreat Dis Int. 2018. PMID: 29861325 Review.
Cited by
-
Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.Front Immunol. 2021 Oct 4;12:765101. doi: 10.3389/fimmu.2021.765101. eCollection 2021. Front Immunol. 2021. PMID: 34675942 Free PMC article. Review.
-
Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.Cell Adh Migr. 2023 Dec;17(1):1-21. doi: 10.1080/19336918.2023.2258539. Epub 2023 Sep 19. Cell Adh Migr. 2023. PMID: 37726886 Free PMC article. Review.
-
Immunotherapy for hepatocellular carcinoma: Current status and future perspectives.World J Gastroenterol. 2023 Feb 14;29(6):1054-1075. doi: 10.3748/wjg.v29.i6.1054. World J Gastroenterol. 2023. PMID: 36844141 Free PMC article. Review.
-
Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma.Transl Gastroenterol Hepatol. 2018 May 2;3:24. doi: 10.21037/tgh.2018.04.05. eCollection 2018. Transl Gastroenterol Hepatol. 2018. PMID: 29971255 Free PMC article. Review.
-
Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver.Theranostics. 2021 Jan 1;11(1):194-208. doi: 10.7150/thno.44979. eCollection 2021. Theranostics. 2021. PMID: 33391470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical